ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
2
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
2
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Estrogen and Progesterone API Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-11P17136
Home | Market Reports | Health| Pharmacy
Global Estrogen and Progesterone API Market Research Report 2024
BUY CHAPTERS

Global Estrogen and Progesterone API Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-11P17136
Report
November 2025
Pages:161
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Symbiotec
Valdepharm (Fareva)
Gonane Pharma
Aspen API
Gedeon Richter
Zhejiang Xianju Pharmaceutical
Humanwell Healthcare
Hunan Norchem Pharmaceutical
Zhejiang Xianju Xianle Pharmaceutical

Estrogen and Progesterone API Market

The global Estrogen and Progesterone API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
From a downstream perspective, Oral Preparation accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Estrogen and Progesterone API leading manufacturers including Pfizer, EUROAPI, Symbiotec, Valdepharm (Fareva), Gonane Pharma, Aspen API, Gedeon Richter, Zhejiang Xianju Pharmaceutical, Humanwell Healthcare, Hunan Norchem Pharmaceutical, etc., dominate supply; the top five capture approximately % of global revenue, with Pfizer leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Estrogen and Progesterone API market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Estrogen and Progesterone API Market Report

Report Metric Details
Report Name Estrogen and Progesterone API Market
Segment by Type
  • Estrogens
  • Progestins
Segment by Application
  • Oral Preparation
  • Topical Preparations
  • Injection
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer, EUROAPI, Symbiotec, Valdepharm (Fareva), Gonane Pharma, Aspen API, Gedeon Richter, Zhejiang Xianju Pharmaceutical, Humanwell Healthcare, Hunan Norchem Pharmaceutical, Zhejiang Xianju Xianle Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Estrogen and Progesterone API study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Estrogen and Progesterone API Market report?

Ans: The main players in the Estrogen and Progesterone API Market are Pfizer, EUROAPI, Symbiotec, Valdepharm (Fareva), Gonane Pharma, Aspen API, Gedeon Richter, Zhejiang Xianju Pharmaceutical, Humanwell Healthcare, Hunan Norchem Pharmaceutical, Zhejiang Xianju Xianle Pharmaceutical

What are the Application segmentation covered in the Estrogen and Progesterone API Market report?

Ans: The Applications covered in the Estrogen and Progesterone API Market report are Oral Preparation, Topical Preparations, Injection

What are the Type segmentation covered in the Estrogen and Progesterone API Market report?

Ans: The Types covered in the Estrogen and Progesterone API Market report are Estrogens, Progestins

1 Study Coverage
1.1 Introduction to Estrogen and Progesterone API: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Estrogen and Progesterone API Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Estrogens
1.2.3 Progestins
1.3 Market Segmentation by Application
1.3.1 Global Estrogen and Progesterone API Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Oral Preparation
1.3.3 Topical Preparations
1.3.4 Injection
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Estrogen and Progesterone API Revenue Estimates and Forecasts 2020-2031
2.2 Global Estrogen and Progesterone API Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Estrogen and Progesterone API Sales Estimates and Forecasts 2020-2031
2.4 Global Estrogen and Progesterone API Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Estrogen and Progesterone API Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Estrogen and Progesterone API Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Estrogens Market Size by Manufacturers
3.5.2 Progestins Market Size by Manufacturers
3.6 Global Estrogen and Progesterone API Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Estrogen and Progesterone API Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Estrogen and Progesterone API Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Estrogen and Progesterone API Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Estrogen and Progesterone API Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Estrogen and Progesterone API Sales and Revenue by Type (2020-2031)
6.4 North America Estrogen and Progesterone API Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Estrogen and Progesterone API Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Estrogen and Progesterone API Sales and Revenue by Type (2020-2031)
7.4 Europe Estrogen and Progesterone API Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Estrogen and Progesterone API Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Estrogen and Progesterone API Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Estrogen and Progesterone API Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Estrogen and Progesterone API Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Estrogen and Progesterone API Sales and Revenue by Type (2020-2031)
9.4 Central and South America Estrogen and Progesterone API Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Estrogen and Progesterone API Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Estrogen and Progesterone API Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Estrogen and Progesterone API Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Estrogen and Progesterone API Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Estrogen and Progesterone API Product Models, Descriptions and Specifications
11.1.4 Pfizer Estrogen and Progesterone API Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Pfizer Estrogen and Progesterone API Sales by Product in 2024
11.1.6 Pfizer Estrogen and Progesterone API Sales by Application in 2024
11.1.7 Pfizer Estrogen and Progesterone API Sales by Geographic Area in 2024
11.1.8 Pfizer Estrogen and Progesterone API SWOT Analysis
11.1.9 Pfizer Recent Developments
11.2 EUROAPI
11.2.1 EUROAPI Corporation Information
11.2.2 EUROAPI Business Overview
11.2.3 EUROAPI Estrogen and Progesterone API Product Models, Descriptions and Specifications
11.2.4 EUROAPI Estrogen and Progesterone API Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 EUROAPI Estrogen and Progesterone API Sales by Product in 2024
11.2.6 EUROAPI Estrogen and Progesterone API Sales by Application in 2024
11.2.7 EUROAPI Estrogen and Progesterone API Sales by Geographic Area in 2024
11.2.8 EUROAPI Estrogen and Progesterone API SWOT Analysis
11.2.9 EUROAPI Recent Developments
11.3 Symbiotec
11.3.1 Symbiotec Corporation Information
11.3.2 Symbiotec Business Overview
11.3.3 Symbiotec Estrogen and Progesterone API Product Models, Descriptions and Specifications
11.3.4 Symbiotec Estrogen and Progesterone API Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Symbiotec Estrogen and Progesterone API Sales by Product in 2024
11.3.6 Symbiotec Estrogen and Progesterone API Sales by Application in 2024
11.3.7 Symbiotec Estrogen and Progesterone API Sales by Geographic Area in 2024
11.3.8 Symbiotec Estrogen and Progesterone API SWOT Analysis
11.3.9 Symbiotec Recent Developments
11.4 Valdepharm (Fareva)
11.4.1 Valdepharm (Fareva) Corporation Information
11.4.2 Valdepharm (Fareva) Business Overview
11.4.3 Valdepharm (Fareva) Estrogen and Progesterone API Product Models, Descriptions and Specifications
11.4.4 Valdepharm (Fareva) Estrogen and Progesterone API Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Valdepharm (Fareva) Estrogen and Progesterone API Sales by Product in 2024
11.4.6 Valdepharm (Fareva) Estrogen and Progesterone API Sales by Application in 2024
11.4.7 Valdepharm (Fareva) Estrogen and Progesterone API Sales by Geographic Area in 2024
11.4.8 Valdepharm (Fareva) Estrogen and Progesterone API SWOT Analysis
11.4.9 Valdepharm (Fareva) Recent Developments
11.5 Gonane Pharma
11.5.1 Gonane Pharma Corporation Information
11.5.2 Gonane Pharma Business Overview
11.5.3 Gonane Pharma Estrogen and Progesterone API Product Models, Descriptions and Specifications
11.5.4 Gonane Pharma Estrogen and Progesterone API Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Gonane Pharma Estrogen and Progesterone API Sales by Product in 2024
11.5.6 Gonane Pharma Estrogen and Progesterone API Sales by Application in 2024
11.5.7 Gonane Pharma Estrogen and Progesterone API Sales by Geographic Area in 2024
11.5.8 Gonane Pharma Estrogen and Progesterone API SWOT Analysis
11.5.9 Gonane Pharma Recent Developments
11.6 Aspen API
11.6.1 Aspen API Corporation Information
11.6.2 Aspen API Business Overview
11.6.3 Aspen API Estrogen and Progesterone API Product Models, Descriptions and Specifications
11.6.4 Aspen API Estrogen and Progesterone API Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Aspen API Recent Developments
11.7 Gedeon Richter
11.7.1 Gedeon Richter Corporation Information
11.7.2 Gedeon Richter Business Overview
11.7.3 Gedeon Richter Estrogen and Progesterone API Product Models, Descriptions and Specifications
11.7.4 Gedeon Richter Estrogen and Progesterone API Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Gedeon Richter Recent Developments
11.8 Zhejiang Xianju Pharmaceutical
11.8.1 Zhejiang Xianju Pharmaceutical Corporation Information
11.8.2 Zhejiang Xianju Pharmaceutical Business Overview
11.8.3 Zhejiang Xianju Pharmaceutical Estrogen and Progesterone API Product Models, Descriptions and Specifications
11.8.4 Zhejiang Xianju Pharmaceutical Estrogen and Progesterone API Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Zhejiang Xianju Pharmaceutical Recent Developments
11.9 Humanwell Healthcare
11.9.1 Humanwell Healthcare Corporation Information
11.9.2 Humanwell Healthcare Business Overview
11.9.3 Humanwell Healthcare Estrogen and Progesterone API Product Models, Descriptions and Specifications
11.9.4 Humanwell Healthcare Estrogen and Progesterone API Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Humanwell Healthcare Recent Developments
11.10 Hunan Norchem Pharmaceutical
11.10.1 Hunan Norchem Pharmaceutical Corporation Information
11.10.2 Hunan Norchem Pharmaceutical Business Overview
11.10.3 Hunan Norchem Pharmaceutical Estrogen and Progesterone API Product Models, Descriptions and Specifications
11.10.4 Hunan Norchem Pharmaceutical Estrogen and Progesterone API Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Hunan Norchem Pharmaceutical Recent Developments
11.11 Zhejiang Xianju Xianle Pharmaceutical
11.11.1 Zhejiang Xianju Xianle Pharmaceutical Corporation Information
11.11.2 Zhejiang Xianju Xianle Pharmaceutical Business Overview
11.11.3 Zhejiang Xianju Xianle Pharmaceutical Estrogen and Progesterone API Product Models, Descriptions and Specifications
11.11.4 Zhejiang Xianju Xianle Pharmaceutical Estrogen and Progesterone API Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Zhejiang Xianju Xianle Pharmaceutical Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Estrogen and Progesterone API Industry Chain
12.2 Estrogen and Progesterone API Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Estrogen and Progesterone API Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Estrogen and Progesterone API Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Estrogen and Progesterone API Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Estrogen and Progesterone API Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Symbiotec
Valdepharm (Fareva)
Gonane Pharma
Aspen API
Gedeon Richter
Zhejiang Xianju Pharmaceutical
Humanwell Healthcare
Hunan Norchem Pharmaceutical
Zhejiang Xianju Xianle Pharmaceutical
List of Tables
 Table 1. Global Estrogen and Progesterone API Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Estrogen and Progesterone API Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Estrogen and Progesterone API Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Estrogen and Progesterone API Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Estrogen and Progesterone API Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Estrogen and Progesterone API Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 7. Global Estrogen and Progesterone API Sales by Region (2020-2025) & (Tons)
 Table 8. Global Estrogen and Progesterone API Sales by Region (2026-2031) & (Tons)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Estrogen and Progesterone API Sales by Manufacturers (2020-2025) & (Tons)
 Table 11. Global Estrogen and Progesterone API Sales Share by Manufacturers (2020-2025)
 Table 12. Global Estrogen and Progesterone API Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Estrogen and Progesterone API Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Estrogen and Progesterone API by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Estrogen and Progesterone API as of 2024)
 Table 16. Global Estrogen and Progesterone API Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Estrogen and Progesterone API Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Kg)
 Table 18. Key Manufacturers Estrogen and Progesterone API Manufacturing Base and Headquarters
 Table 19. Global Estrogen and Progesterone API Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Estrogen and Progesterone API Sales by Type (2020-2025) & (Tons)
 Table 23. Global Estrogen and Progesterone API Sales by Type (2026-2031) & (Tons)
 Table 24. Global Estrogen and Progesterone API Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Estrogen and Progesterone API Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Estrogen and Progesterone API ASP by Type (2020-2031) & (US$/Kg)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Estrogen and Progesterone API Sales by Application (2020-2025) & (Tons)
 Table 29. Global Estrogen and Progesterone API Sales by Application (2026-2031) & (Tons)
 Table 30. Estrogen and Progesterone API High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Estrogen and Progesterone API Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Estrogen and Progesterone API Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Estrogen and Progesterone API ASP by Application (2020-2031) & (US$/Kg)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Estrogen and Progesterone API Growth Accelerators and Market Barriers
 Table 37. North America Estrogen and Progesterone API Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Estrogen and Progesterone API Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Estrogen and Progesterone API Growth Accelerators and Market Barriers
 Table 40. Europe Estrogen and Progesterone API Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Estrogen and Progesterone API Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Estrogen and Progesterone API Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Estrogen and Progesterone API Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Estrogen and Progesterone API Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Estrogen and Progesterone API Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Estrogen and Progesterone API Investment Opportunities and Key Challenges
 Table 47. Central and South America Estrogen and Progesterone API Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Estrogen and Progesterone API Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Estrogen and Progesterone API Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Pfizer Corporation Information
 Table 51. Pfizer Description and Major Businesses
 Table 52. Pfizer Product Models, Descriptions and Specifications
 Table 53. Pfizer Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 54. Pfizer Sales Value Proportion by Product in 2024
 Table 55. Pfizer Sales Value Proportion by Application in 2024
 Table 56. Pfizer Sales Value Proportion by Geographic Area in 2024
 Table 57. Pfizer Estrogen and Progesterone API SWOT Analysis
 Table 58. Pfizer Recent Developments
 Table 59. EUROAPI Corporation Information
 Table 60. EUROAPI Description and Major Businesses
 Table 61. EUROAPI Product Models, Descriptions and Specifications
 Table 62. EUROAPI Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 63. EUROAPI Sales Value Proportion by Product in 2024
 Table 64. EUROAPI Sales Value Proportion by Application in 2024
 Table 65. EUROAPI Sales Value Proportion by Geographic Area in 2024
 Table 66. EUROAPI Estrogen and Progesterone API SWOT Analysis
 Table 67. EUROAPI Recent Developments
 Table 68. Symbiotec Corporation Information
 Table 69. Symbiotec Description and Major Businesses
 Table 70. Symbiotec Product Models, Descriptions and Specifications
 Table 71. Symbiotec Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 72. Symbiotec Sales Value Proportion by Product in 2024
 Table 73. Symbiotec Sales Value Proportion by Application in 2024
 Table 74. Symbiotec Sales Value Proportion by Geographic Area in 2024
 Table 75. Symbiotec Estrogen and Progesterone API SWOT Analysis
 Table 76. Symbiotec Recent Developments
 Table 77. Valdepharm (Fareva) Corporation Information
 Table 78. Valdepharm (Fareva) Description and Major Businesses
 Table 79. Valdepharm (Fareva) Product Models, Descriptions and Specifications
 Table 80. Valdepharm (Fareva) Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 81. Valdepharm (Fareva) Sales Value Proportion by Product in 2024
 Table 82. Valdepharm (Fareva) Sales Value Proportion by Application in 2024
 Table 83. Valdepharm (Fareva) Sales Value Proportion by Geographic Area in 2024
 Table 84. Valdepharm (Fareva) Estrogen and Progesterone API SWOT Analysis
 Table 85. Valdepharm (Fareva) Recent Developments
 Table 86. Gonane Pharma Corporation Information
 Table 87. Gonane Pharma Description and Major Businesses
 Table 88. Gonane Pharma Product Models, Descriptions and Specifications
 Table 89. Gonane Pharma Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 90. Gonane Pharma Sales Value Proportion by Product in 2024
 Table 91. Gonane Pharma Sales Value Proportion by Application in 2024
 Table 92. Gonane Pharma Sales Value Proportion by Geographic Area in 2024
 Table 93. Gonane Pharma Estrogen and Progesterone API SWOT Analysis
 Table 94. Gonane Pharma Recent Developments
 Table 95. Aspen API Corporation Information
 Table 96. Aspen API Description and Major Businesses
 Table 97. Aspen API Product Models, Descriptions and Specifications
 Table 98. Aspen API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 99. Aspen API Recent Developments
 Table 100. Gedeon Richter Corporation Information
 Table 101. Gedeon Richter Description and Major Businesses
 Table 102. Gedeon Richter Product Models, Descriptions and Specifications
 Table 103. Gedeon Richter Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 104. Gedeon Richter Recent Developments
 Table 105. Zhejiang Xianju Pharmaceutical Corporation Information
 Table 106. Zhejiang Xianju Pharmaceutical Description and Major Businesses
 Table 107. Zhejiang Xianju Pharmaceutical Product Models, Descriptions and Specifications
 Table 108. Zhejiang Xianju Pharmaceutical Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 109. Zhejiang Xianju Pharmaceutical Recent Developments
 Table 110. Humanwell Healthcare Corporation Information
 Table 111. Humanwell Healthcare Description and Major Businesses
 Table 112. Humanwell Healthcare Product Models, Descriptions and Specifications
 Table 113. Humanwell Healthcare Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 114. Humanwell Healthcare Recent Developments
 Table 115. Hunan Norchem Pharmaceutical Corporation Information
 Table 116. Hunan Norchem Pharmaceutical Description and Major Businesses
 Table 117. Hunan Norchem Pharmaceutical Product Models, Descriptions and Specifications
 Table 118. Hunan Norchem Pharmaceutical Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 119. Hunan Norchem Pharmaceutical Recent Developments
 Table 120. Zhejiang Xianju Xianle Pharmaceutical Corporation Information
 Table 121. Zhejiang Xianju Xianle Pharmaceutical Description and Major Businesses
 Table 122. Zhejiang Xianju Xianle Pharmaceutical Product Models, Descriptions and Specifications
 Table 123. Zhejiang Xianju Xianle Pharmaceutical Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 124. Zhejiang Xianju Xianle Pharmaceutical Recent Developments
 Table 125. Key Raw Materials Distribution
 Table 126. Raw Materials Key Suppliers
 Table 127. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 128. Milestones in Production Technology Evolution
 Table 129. Distributors List
 Table 130. Market Trends and Market Evolution
 Table 131. Market Drivers and Opportunities
 Table 132. Market Challenges, Risks, and Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources


List of Figures
 Figure 1. Estrogen and Progesterone API Product Picture
 Figure 2. Global Estrogen and Progesterone API Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Estrogens Product Picture
 Figure 4. Progestins Product Picture
 Figure 5. Global Estrogen and Progesterone API Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Oral Preparation
 Figure 7. Topical Preparations
 Figure 8. Injection
 Figure 9. Estrogen and Progesterone API Report Years Considered
 Figure 10. Global Estrogen and Progesterone API Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Estrogen and Progesterone API Revenue (2020-2031) & (US$ Million)
 Figure 12. Global Estrogen and Progesterone API Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 13. Global Estrogen and Progesterone API Revenue Market Share by Region (2020-2031)
 Figure 14. Global Estrogen and Progesterone API Sales (2020-2031) & (Tons)
 Figure 15. Global Estrogen and Progesterone API Sales (CAGR) by Region (2020-2031) (Tons)
 Figure 16. Global Estrogen and Progesterone API Sales Market Share by Region (2020-2031)
 Figure 17. Top 5 and Top 10 Manufacturers Estrogen and Progesterone API Sales Volume Market Share in 2024
 Figure 18. Global Estrogen and Progesterone API Revenue Market Share Ranking (2024)
 Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 20. Estrogens Revenue Market Share by Manufacturer in 2024
 Figure 21. Progestins Revenue Market Share by Manufacturer in 2024
 Figure 22. Global Estrogen and Progesterone API Sales Market Share by Type (2020-2031)
 Figure 23. Global Estrogen and Progesterone API Revenue Market Share by Type (2020-2031)
 Figure 24. Global Estrogen and Progesterone API Sales Market Share by Application (2020-2031)
 Figure 25. Global Estrogen and Progesterone API Revenue Market Share by Application (2020-2031)
 Figure 26. North America Estrogen and Progesterone API Sales YoY (2020-2031) & (Tons)
 Figure 27. North America Estrogen and Progesterone API Revenue YoY (2020-2031) & (US$ Million)
 Figure 28. North America Top 5 Manufacturers Estrogen and Progesterone API Sales Revenue (US$ Million) in 2024
 Figure 29. North America Estrogen and Progesterone API Sales Volume (Tons) by Type (2020- 2031)
 Figure 30. North America Estrogen and Progesterone API Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 31. North America Estrogen and Progesterone API Sales Volume (Tons) by Application (2020-2031)
 Figure 32. North America Estrogen and Progesterone API Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 33. US Estrogen and Progesterone API Revenue (2020-2031) & (US$ Million)
 Figure 34. Canada Estrogen and Progesterone API Revenue (2020-2031) & (US$ Million)
 Figure 35. Mexico Estrogen and Progesterone API Revenue (2020-2031) & (US$ Million)
 Figure 36. Europe Estrogen and Progesterone API Sales YoY (2020-2031) & (Tons)
 Figure 37. Europe Estrogen and Progesterone API Revenue YoY (2020-2031) & (US$ Million)
 Figure 38. Europe Top 5 Manufacturers Estrogen and Progesterone API Sales Revenue (US$ Million) in 2024
 Figure 39. Europe Estrogen and Progesterone API Sales Volume (Tons) by Type (2020-2031)
 Figure 40. Europe Estrogen and Progesterone API Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 41. Europe Estrogen and Progesterone API Sales Volume (Tons) by Application (2020-2031)
 Figure 42. Europe Estrogen and Progesterone API Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 43. Germany Estrogen and Progesterone API Revenue (2020-2031) & (US$ Million)
 Figure 44. France Estrogen and Progesterone API Revenue (2020-2031) & (US$ Million)
 Figure 45. U.K. Estrogen and Progesterone API Revenue (2020-2031) & (US$ Million)
 Figure 46. Italy Estrogen and Progesterone API Revenue (2020-2031) & (US$ Million)
 Figure 47. Russia Estrogen and Progesterone API Revenue (2020-2031) & (US$ Million)
 Figure 48. Asia-Pacific Estrogen and Progesterone API Sales YoY (2020-2031) & (Tons)
 Figure 49. Asia-Pacific Estrogen and Progesterone API Revenue YoY (2020-2031) & (US$ Million)
 Figure 50. Asia-Pacific Top 8 Manufacturers Estrogen and Progesterone API Sales Revenue (US$ Million) in 2024
 Figure 51. Asia-Pacific Estrogen and Progesterone API Sales Volume (Tons) by Type (2020- 2031)
 Figure 52. Asia-Pacific Estrogen and Progesterone API Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 53. Asia-Pacific Estrogen and Progesterone API Sales Volume (Tons) by Application (2020-2031)
 Figure 54. Asia-Pacific Estrogen and Progesterone API Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 55. Indonesia Estrogen and Progesterone API Revenue (2020-2031) & (US$ Million)
 Figure 56. Japan Estrogen and Progesterone API Revenue (2020-2031) & (US$ Million)
 Figure 57. South Korea Estrogen and Progesterone API Revenue (2020-2031) & (US$ Million)
 Figure 58. China Taiwan Estrogen and Progesterone API Revenue (2020-2031) & (US$ Million)
 Figure 59. India Estrogen and Progesterone API Revenue (2020-2031) & (US$ Million)
 Figure 60. Central and South America Estrogen and Progesterone API Sales YoY (2020-2031) & (Tons)
 Figure 61. Central and South America Estrogen and Progesterone API Revenue YoY (2020-2031) & (US$ Million)
 Figure 62. Central and South America Top 5 Manufacturers Estrogen and Progesterone API Sales Revenue (US$ Million) in 2024
 Figure 63. Central and South America Estrogen and Progesterone API Sales Volume (Tons) by Type (2021-2031)
 Figure 64. Central and South America Estrogen and Progesterone API Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 65. Central and South America Estrogen and Progesterone API Sales Volume (Tons) by Application (2020-2031)
 Figure 66. Central and South America Estrogen and Progesterone API Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 67. Brazil Estrogen and Progesterone API Revenue (2020-2025) & (US$ Million)
 Figure 68. Argentina Estrogen and Progesterone API Revenue (2020-2025) & (US$ Million)
 Figure 69. Middle East, and Africa Estrogen and Progesterone API Sales YoY (2020-2031) & (Tons)
 Figure 70. Middle East and Africa Estrogen and Progesterone API Revenue YoY (2020-2031) & (US$ Million)
 Figure 71. Middle East and Africa Top 5 Manufacturers Estrogen and Progesterone API Sales Revenue (US$ Million) in 2024
 Figure 72. Middle East and Africa Estrogen and Progesterone API Sales Volume (Tons) by Type (2021-2031)
 Figure 73. South America Estrogen and Progesterone API Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 74. Middle East and Africa Estrogen and Progesterone API Sales Volume (Tons) by Application (2020-2031)
 Figure 75. Middle East and Africa Estrogen and Progesterone API Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 76. GCC Countries Estrogen and Progesterone API Revenue (2020-2025) & (US$ Million)
 Figure 77. Turkey Estrogen and Progesterone API Revenue (2020-2025) & (US$ Million)
 Figure 78. Egypt Estrogen and Progesterone API Revenue (2020-2025) & (US$ Million)
 Figure 79. South Africa Estrogen and Progesterone API Revenue (2020-2025) & (US$ Million)
 Figure 80. Estrogen and Progesterone API Industry Chain Mapping
 Figure 81. Regional Estrogen and Progesterone API Manufacturing Base Distribution (%)
 Figure 82. Global Estrogen and Progesterone API Production Market Share by Region (2020-2031)
 Figure 83. Estrogen and Progesterone API Production Process
 Figure 84. Regional Estrogen and Progesterone API Production Cost Structure
 Figure 85. Channels of Distribution (Direct Vs Distribution)
 Figure 86. Bottom-up and Top-down Approaches for This Report
 Figure 87. Data Triangulation
 Figure 88. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Progesterone API Market Research Report 2025
Global Estrogen API Market Research Report 2024
Global β Estradiol API Market Research Report 2024
Global Hydroxyprogesterone Caproate API Market Research Report 2024
Global Eplerenone API Market Research Report 2025
Global Mifepristone API Market Research Report 2025
Global Estrogen Receptor Market Research Report 2024
Global Dydrogesterone API Market Research Report 2024
Global Progesterone Receptor Agonist Market Research Report 2024
Global Progesterone Injection Market Research Report 2024
Global Ethinylestradiol API Market Research Report 2025
Global Hydrocortisone API Market Research Report 2024
Steroid APIs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Estrogen Receptor Beta Market Research Report 2024
Global Exemestane API Market Research Report 2024
Estrogen Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Steroid Hormones Market Research Report 2025
Global Estradiol Valerate Market Research Report 2025
Global Prednisolone API Market Research Report 2025
Global Sex Hormones API Market Research Report 2024

RELATED REPORTS

Global Levothyroxine Sodium Tablets Hormone Medication Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-25N19924
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Needle Free Allergy Therapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24B19783
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Hydrotalcite Antacid Chewable Tablets Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20305
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Dual Orexin Receptor Antagonist Sleeping Pills Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-12S20176
Mon Nov 24 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions